Searched for
INVESTIGATIONAL DRUG REMDESIVIR
Remdesivir used ‘sparingly’ amid concerns over supplyThree leading private hospitals in Delhi confirmed to ET that they are giving remdesivir only to patients whose condition is significantly ...- Government steps in to ramp up remdesivir supply, bring down its price“Fast-track approval has been given for seven additional sites having the production capacity of 1 million vials/month to six manufacturers...
- Government bans export of Remdesivir till Covid-19 situation improvesA state health department official said the state has more stock than that. Maharashtra is also planning to put a ban on the retail sale of...
- Remdesivir not for home use, meant for serious patients, says Govt amid rise in demandAt a weekly press conference, NITI Aayog member (Health) Dr V K Paul said, "Remdesivir is to be used only in those who require hospitalisat...
- DCGI rejects Dr Reddy's proposal seeking change in regulatory approval status for remdesivirDr Reddy’s had approached the Subject Expert committee (SEC) that advises the Drug Controller General of India (DCGI) on applications seeki...
- Remdesivir use may continue in India as few options in sightDoctors say they find Remdesivir helps reduce viral load in moderate cases. Some, however, question its effectiveness and price. They have ...
- Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800 per 100 mg vialZydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Li...
- Jubilant Life Sciences arm launches Remdesivir injection in the Indian marketJubilant Generics will make the drug available to over 1,000 hospitals providing Covid-19 treatment in India through its distribution netwo...
- Remdesivir sells at 10x prices, NPPA unable to regulate as it's not notified as a 'drug'The NPPA can only control prices of devices and products that are defined as drugs under the Drugs and Cosmetics Act. A product or device t...
- Health ministry asks DGCI to ensure equitable distribution of Remdesivir, Tocilizumab drugsThe ministry has shot off a letter to the Drugs Controller General of India (DCGI), asking it to ascertain how many states and Union territ...
- This pharma stock rallies 4% as firm gets DCGI nod for Covid drug, RJ ups stakeThe company will distribute the drug in the Indian market through its network and it will be available by the first week of August 2020, th...
- Hetero starts supply of 60,000 vials of generic Remdesvir for treatment of Covid-19 patientsCovifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitali...
- Doctors advised to use Remdesivir on COVID-19 patients strictly under laid-down protocolTo prevent black-marketing and overcharging of the drug, India's drug regulator Drugs Controller General of India (DCGI) has asked manufact...
- Cipla, Hetero receive drug controller's emergency approval for Remdesivir for severe Covid-19 patientsRemdesivir is an experimental drug from drug maker Gilead that has shown to bring down the viral load on patients and hence help in faster ...
- Hetero gets DCGI nod to launch Remdesivir for Covid-19 treatmentHetero will produce and launch the first generic Remdesivir under Covifor brand in India following positive clinical outcomes under a licen...
- DCGI gives nod to Hetero Labs and Cipla to manufacture and market remdesivirThe emergency approval is given to an unapproved therapy for compassionate use provided drug companies share the clinical data of the drug ...
- Dr Reddy’s inks licensing pact with Gilead for Remdesivir to treat Covid-19The Hyderabad headquartered drug maker will obtain technology transfer from Gilead for manufacturing of the drug wherein the Indian firm wo...
- Gilead scouting for partners in India, Pakistan for remdesivirRecent clinical trial results and the decision by the US Food and Drug Administration to issue 'Emergency Use Authorisation' for remdesivir...
- FDA allows emergency use of anti-viral vaccine Remdesivir to treat COVID-19 patientsThe Food and Drug Administration (FDA) gave emergency use authorisation (EUA) for the use of investigational anti-viral Remdesivir in the t...
- ICMR may use remdesivir if local companies can manufacture itThe Indian Council of Medical Research (ICMR) said it will consider using remdesivir, an experimental drug made by Gilead Sciences, to trea...
Load More
